EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Dynamic, Inflammation-Aware Framework for Safe Clozapine Prescribing in East Asian Populations

Takahiko Nagamine

Clinics and Practice · 14.11.2026 · 16 (11) · 214

DOI: 10.3390/clinpract16110214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinics and Practice, online erschienen am 14.11.2026. Verfasst von Takahiko Nagamine. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia, yet it remains underused in many East Asian settings. Lower average dose requirements have often been attributed to CYP1A2 genetic variation, but genotype alone does not adequately explain interindividual or within-patient variability.

Methods

This narrative review synthesises targeted literature on clozapine pharmacokinetics, CYP1A2 regulation, therapeutic drug monitoring (TDM), inflammation and clinically important adverse effects.

Results

Clozapine exposure reflects both relatively stable characteristics and time-varying factors, including smoking, interacting medicines, adherence and inflammatory illness. Cytokine-mediated CYP1A2 suppression provides a plausible mechanism for concentration increases during inflammation, although the causal contribution and direction of the proposed feedback relationship require prospective study. The review presents a conceptual, three-phase framework for integrating clinical assessment, inflammatory markers and TDM, with attention to metabolic, respiratory, gastrointestinal and haematological risks. The framework is not a validated dosing algorithm and does not replace established guidance or mandatory blood-monitoring programmes.

Conclusions

This framework offers a testable approach to longitudinal clozapine assessment in East Asian populations; its clinical utility and generalisability require external prospective validation.

Zitieren

APA

Nagamine, T. (2026). A Dynamic, Inflammation-Aware Framework for Safe Clozapine Prescribing in East Asian Populations. Clinics and Practice, 16(11), 214. https://doi.org/10.3390/clinpract16110214

Vancouver

Nagamine T. A Dynamic, Inflammation-Aware Framework for Safe Clozapine Prescribing in East Asian Populations. Clinics and Practice. 2026;16(11):214. doi:10.3390/clinpract16110214

BibTeX
@article{Nagamine2026,
  author = {Nagamine, Takahiko},
  title = {A Dynamic, Inflammation-Aware Framework for Safe Clozapine Prescribing in East Asian Populations},
  journal = {Clinics and Practice},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {214},
  doi = {10.3390/clinpract16110214}
}
Kostenlos starten →